首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells.
【24h】

Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells.

机译:骨髓移植后患有急性移植物抗宿主病的患者具有功能性CD4 + CD25hiFoxp3 +调节性T细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute Graft-Versus-Host Disease (aGVHD), mediated by CD4(+) and CD8(+) effector T cells, is a life-threatening complication in hematopoietic stem cell (HSC) transplantation. Naturally-occurring CD4(+)CD25(hi)(Foxp3(+)) regulatory T cells (T(reg)) have been shown to modulate tolerance to aGVHD in murine graft models. In this report, we investigated their role in the prevention of aGVHD in patients transplanted with bone-marrow-derived HSC. When CD4(+)CD25(hi)Foxp3(+) T cells were isolated from bone-marrow grafts, they showed no suppressive activity. The analysis of their function in patients suffering from aGVHD after transplantation revealed a gain of suppressive activity indicating their inability to control the aGVHD induction. Thus, our findings clearly demonstrate that CD4(+)CD25(+) and CD4(+)CD25(hi)Foxp3(+) T cells, when administered in steady-state physiological conditions, do not influence the outcome of aGVHD after bone-marrow transplantation.
机译:CD4(+)和CD8(+)效应T细胞介导的急性移植物抗宿主病(aGVHD)是造血干细胞(HSC)移植中危及生命的并发症。天然存在的CD4(+)CD25(hi)(Foxp3(+))调节性T细胞(T(reg))已显示出可调节鼠移植模型对aGVHD的耐受性。在本报告中,我们调查了它们在预防骨髓源性HSC移植患者中预防aGVHD中的作用。当从骨髓移植物中分离出CD4(+)CD25(hi)Foxp3(+)T细胞时,它们没有抑制活性。对移植后患有aGVHD的患者的功能进行的分析显示,其抑制活性有所提高,表明他们无法控制aGVHD的诱导。因此,我们的发现清楚地表明,在稳态生理条件下给药时,CD4(+)CD25(+)和CD4(+)CD25(hi)Foxp3(+)T细胞不会影响骨转移后aGVHD的结果骨髓移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号